PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells
Wen-Pin Su,1,2 Fong-Yu Cheng,3 Dar-Bin Shieh,3–6 Chen-Sheng Yeh,5–7 Wu-Chou Su1,2,81Graduate Institute of Clinical Medicine, College of Medicine, National Cheng Kung University; 2Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine...
Main Authors: | Su WP, Cheng FY, Shieh DB, Yeh CS, Su WC |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-08-01
|
Series: | International Journal of Nanomedicine |
Online Access: | http://www.dovepress.com/plga-nanoparticles-codeliver-paclitaxel-and-stat3-sirna-to-overcome-ce-a10609 |
Similar Items
-
PLGA nanoparticles co-delivering MDR1 and BCL2 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer
by: Chitra Risnayanti, et al.
Published: (2018-05-01) -
Nanoparticles Codelivering mRNA and SiRNA for Simultaneous Restoration and Silencing of Gene/Protein Expression In Vitro and In Vivo
by: Shireesha Manturthi, et al.
Published: (2024-11-01) -
Preparation of siRNA–PLGA/Fabʹ–PLGA mixed micellar system with target cell-specific recognition
by: Mai Hazekawa, et al.
Published: (2021-08-01) -
Pronounced induction of endoplasmic reticulum stress and tumor suppression by surfactant-free poly (lactic-co-glycolic acid) nanoparticles via modulation of the PI3K signaling pathway
by: Hou CC, et al.
Published: (2013-07-01) -
Nucleocytoplasmic transport blockage by SV40 peptide-modified gold nanoparticles induces cellular autophagy
by: Tsai TL, et al.
Published: (2012-10-01)